Keisuke Taniguchi Selected Research

Keisuke Taniguchi Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 04/2010
5	Inflammation (Inflammations) 12/2022 - 09/2008
3	Infections 11/2022 - 04/2010
2	Obesity 09/2023 - 01/2023
2	Granuloma 11/2021 - 04/2010
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 11/2019 - 01/2017
2	Hemorrhage 11/2019 - 12/2013
2	Arthus Reaction 01/2019 - 09/2008
1	Insulin Resistance 02/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024
1	Chronic Renal Insufficiency 09/2023
1	Reperfusion Injury 12/2022
1	Fibrosis (Cirrhosis) 12/2022
1	Vasculitis (Vasculitides) 11/2022
1	Pulmonary Aspergillosis 11/2022
1	Arteritis 11/2022
1	Renal Insufficiency (Renal Failure) 11/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2022
1	Nephritis 11/2022
1	Invasive Pulmonary Aspergillosis 11/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Amyloidosis 11/2021
1	Chronic Granulomatous Disease 11/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Mouth Neoplasms (Oral Cancer) 05/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 11/2019
1	MYH9-Related Disorders 10/2019
1	Proteinuria 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Disease Progression 01/2017
1	Pleurisy (Pleuritis) 12/2013

Drug/Important Bio-Agent (IBA)

3	Triglycerides (Triacylglycerol)IBA 02/2024 - 01/2023
3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2023
3	Anaphylatoxin C5a ReceptorIBA 12/2013 - 09/2008
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2011
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 05/2020
2	YHO-1701IBA 01/2021 - 05/2020
2	ribosomal protein S19IBA 12/2013 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 07/2011 - 01/2011
2	AntibodiesIBA 01/2011 - 09/2008
1	avasimibeIBA 12/2022
1	Sterol O-AcyltransferaseIBA 12/2022
1	SteroidsIBA 11/2022
1	CreatinineIBA 11/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2022
1	AntigensIBA 11/2022
1	Antifungal AgentsIBA 11/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2021
1	Anti-Infective Agents (Microbicides)IBA 11/2021
1	Methylprednisolone FDA LinkGeneric 11/2021
1	Prednisolone (Predate)FDA LinkGeneric 11/2021
1	NADP (NADPH)IBA 11/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	perifosineIBA 01/2021
1	alectinibIBA 01/2021
1	STX-0119IBA 05/2020
1	SurvivinIBA 05/2020
1	Warfarin (Coumadin)FDA LinkGeneric 11/2019
1	Dabigatran FDA Link 11/2019
1	AnticoagulantsIBA 11/2019
1	Enalapril FDA LinkGeneric 10/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2019
1	Neutralizing AntibodiesIBA 12/2013
1	CarrageenanIBA 12/2013
1	matrigelIBA 04/2013
1	AnaphylatoxinsIBA 04/2013
1	Matrix Metalloproteinases (MMPs)IBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	Therapeutic UsesIBA 07/2011
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 04/2010
1	Parathyroid Hormone-Related ProteinIBA 04/2010

Therapy/Procedure

4	Therapeutics 11/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2011
2	Transplantation 07/2011 - 01/2011
1	Renal Dialysis (Hemodialysis) 11/2022
1	Intravenous Injections 01/2019
1	Cesarean Section (Caesarean Section) 01/2017
1	Nephrectomy 04/2010